Pediatric within-day biological variation and quality specifications for 38 biochemical markers in the CALIPER cohort

Dana Bailey1, Victoria Bevilacqua, David A Colantonio

  • 1CALIPER program, Department of Pediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada;

Clinical Chemistry
|December 25, 2013
PubMed

Insights

This study established biological variation for 38 analytes in children, finding differences from adults and aiding pediatric lab quality management. These findings are crucial for monitoring pediatric health and setting quality standards.

Area of Science:

  • Clinical Chemistry
  • Pediatric Physiology
  • Biomarker Analysis

Background:

  • Biological variation studies offer insights into physiological changes within and between individuals.
  • Analyte values are critical for patient monitoring and establishing quality specifications.
  • Previous research has primarily focused on adult populations, leaving a gap in pediatric data.

Purpose of the Study:

  • To evaluate short-term biological variation for 38 chemistry, lipid, enzyme, and protein analytes in a pediatric cohort.
  • To assess the impact of age partitioning on interindividual variation in children.
  • To compare pediatric biological variation data with established adult values.

Main Methods:

  • Collected four plasma samples within 8 hours from 29 healthy children (aged 4-18 years).
  • Analyzed samples in three batches using nested ANOVA to determine within-person and between-person biological variation after outlier exclusion.
  • Established analytical quality specifications using the Fraser method.

Main Results:

  • Established biological variation coefficients and analytical goals for 38 analytes.
  • Identified the need for age partitioning in 6 analytes.
  • Found that 37% of assays exhibited distinct biological variation characteristics compared to adult values, and reported data for two new analytes.

Conclusions:

  • This research is the first to define biological variation and analytical quality specifications for common assays in a pediatric population.
  • The findings provide valuable insights into pediatric physiology and support reference change value calculations.
  • Results aid in clarifying reference interval appropriateness and developing quality management strategies for pediatric laboratories.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Variability: Analysis01:11

Variability: Analysis

Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
954
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
1.0K